![](/img/cover-not-exists.png)
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
Fabrizio Mecenate, Adriano M Pellicelli, Giuseppe Barbaro, Mario Romano, Angelo Barlattani, Ettore Mazzoni, Maria Elena Bonaventura, Lorenzo Nosotti, Pasquale Arcuri, Antonio Picardi, Giorgio BarbarinVolume:
10
Language:
english
DOI:
10.1186/1471-230x-10-21
Date:
December, 2010
File:
PDF, 314 KB
english, 2010